Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.180
-0.040 (-0.95%)
Jul 16, 2026, 4:00 PM EDT - Market closed
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $291.81 million as of July 16, 2026. Its market cap has decreased by -45.13% in one year.
Market Cap
291.81M
Enterprise Value
-252.33M
1-Year Change
-45.13%
Ranking
Category
Stock Price
$4.18
ChartMarket Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $291.81M, an increase of 37.42%. That is a compound annual growth rate of 4.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 291.81M | -40.58% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 313.48M |
| Eledon Pharmaceuticals | 310.76M |
| Lineage Cell Therapeutics | 304.14M |
| Neumora Therapeutics | 302.01M |
| OmniAb | 301.54M |
| Conexeu Sciences | 299.16M |
| InflaRx | 297.53M |
| Opus Genetics | 287.33M |